Literature DB >> 9018500

Surfactant inhibition by plasma: gestational age and surfactant treatment effects in preterm lambs.

M Ikegami1, C M Rebello, A H Jobe.   

Abstract

The preterm infant with respiratory distress syndrome has edematous lungs and small amounts of surfactant that do not function normally. We reported that surfactant recovered from preterm lambs after surfactant treatment can have decreased sensitivity to inhibition of surface tension by plasma. We asked whether this augmented resistance to inhibition was dependent on lung development (gestational age) by testing sensitivity to plasma inhibition of 1) endogenous surfactant from preterm lambs and 2) surfactant from preterm lambs after treatment with an organic solvent-extracted natural sheep surfactant. Surfactant recovered after surfactant treatment of 121- or 128-days-gestation lambs had the same sensitivity to plasma inhibition as did the surfactant used to treat the lambs. Surfactant recovered from 134-days-gestation lambs had decreased sensitivity to inhibition. Lung maturation is a variable influencing surfactant inhibition by plasma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9018500     DOI: 10.1152/jappl.1996.81.6.2517

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  3 in total

Review 1.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Effect of surfactant and partial liquid ventilation treatment on gas exchange and lung mechanics in immature lambs: influence of gestational age.

Authors:  Carmen Rey-Santano; Victoria Mielgo; Elena Gastiasoro; Adolfo Valls-i-Soler; Xabier Murgia
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 3.  Bench-to-bedside review: Ventilator strategies to reduce lung injury -- lessons from pediatric and neonatal intensive care.

Authors:  Sally H Vitali; John H Arnold
Journal:  Crit Care       Date:  2004-11-04       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.